High Water Intake in Polycystic Kidney Disease (DRINK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02933268

Recruitment Status : Completed

First Posted : October 14, 2016

Last Update Posted : January 15, 2019

Sponsor:

Collaborators:

PKD Charity

Addenbrookes Charitable Trust

British Renal Society & British Kidney Patient Association

Information provided by (Responsible Party):

Dr Thomas Hiemstra, University of Cambridge

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	March 31, 2018
Actual Study Completion Date :	July 31, 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

El-Damanawi R, Lee M, Harris T, Mader LB, Bond S, Pavey H, Sandford RN, Wilkinson IB, Burrows A, Woznowski P, Ben-Shlomo Y, Karet Frankl FE, Hiemstra TF. Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial. BMJ Open. 2018 May 9;8(5):e022859. doi: 10.1136/bmjopen-2018-022859.

To Top